Dalal Street Updates: Molbio Dips, Jayaswal Neco Clarifies, Morepen Expands

On September 7 the market’s attention was on a handful of stocks that moved sharply despite a generally flat backdrop on the BSE. Molbio Diagnostics, for instance, saw its share price slip about 2 % even though the company announced a tidy Q2 profit of ₹58.7 crore – a turnaround from a loss of ₹23.7 crore a year earlier. Revenue, on the other hand, surged to ₹408.4 crore, almost quadrupling the ₹99.7 crore recorded in the same quarter last year.

Investors seemed puzzled, perhaps wondering why the earnings uplift didn’t translate into buying pressure. Some analysts hinted that the market may still be weighing the sustainability of that growth, especially given the biotech sector’s typical volatility.

Across the street, Jayaswal Neco Industries (JNIL) managed to claw back about 2 % in its stock price. The bounce came after the firm issued a statement clarifying that it has no direct dealings with Datasel SRL or Neco Defence Munitions – entities that share the same promoter group but operate independently. By emphasizing that there are no transactions linking the companies, JNIL tried to reassure investors that any fallout from the other entities won’t hit its balance sheet.

Meanwhile, Morepen Laboratories enjoyed a steadier rise, climbing roughly 3 % after it announced that the first phase of its manufacturing capacity expansion had wrapped up ahead of schedule. The upgrade lifted the installed reactor capacity for APIs and CDMO work from 535 kilolitres to 614 kilolitres, a clear sign that the company is gearing up to meet growing demand.

Sector‑wise, the mood was mixed. The Nifty IT index slipped nearly 2 %, while the Media index fell a little over 2 % and Real Estate gave back 0.7 %. Telecom managed a modest gain of about 1.5 %. The broader Nifty Midcap index was down 0.2 % and the Small‑Cap index held steady.

Despite these headline moves, market breadth on the BSE stayed positive: out of roughly 3,713 stocks, 1,926 advanced, 1,583 declined and 204 were unchanged. That breadth suggests underlying buying interest even if the marquee indices appeared muted.

Overall, the day underscored how corporate news can sway individual stocks while the larger market continues to tread water, waiting for a clearer directional cue.